| Literature DB >> 27929436 |
Yuzhe Sun1, Zeta Mui2,3, Xuan Liu4, Aldrin Kay-Yuen Yim5,6, Hao Qin7, Fuk-Ling Wong8,9, Ting-Fung Chan10,11, Siu-Ming Yiu12, Hon-Ming Lam13,14, Boon Leong Lim15,16.
Abstract
Small RNAs, including microRNAs (miRNAs) and phased small interfering RNAs (phasiRNAs; from PHAS loci), play key roles in plant development. Cultivated soybean, Glycine max, contributes a great deal to food production, but, compared to its wild kin, Glycine soja, it may lose some genetic information during domestication. In this work, we analyzed the sRNA profiles of different tissues in both cultivated (C08) and wild soybeans (W05) at three stages of development. A total of 443 known miRNAs and 15 novel miRNAs showed varying abundances between different samples, but the miRNA profiles were generally similar in both accessions. Based on a sliding window analysis workflow that we developed, 50 PHAS loci generating 55 21-nucleotide phasiRNAs were identified in C08, and 46 phasiRNAs from 41 PHAS loci were identified in W05. In germinated seedlings, phasiRNAs were more abundant in C08 than in W05. Disease resistant TIR-NB-LRR genes constitute a very large family of PHAS loci. PhasiRNAs were also generated from several loci that encode for NAC transcription factors, Dicer-like 2 (DCL2), Pentatricopeptide Repeat (PPR), and Auxin Signaling F-box 3 (AFB3) proteins. To investigate the possible involvement of miRNAs in initiating the PHAS-phasiRNA pathway, miRNA target predictions were performed and 17 C08 miRNAs and 15 W05 miRNAs were predicted to trigger phasiRNAs biogenesis. In summary, we provide a comprehensive description of the sRNA profiles of wild versus cultivated soybeans, and discuss the possible roles of sRNAs during soybean germination.Entities:
Keywords: Glycine max; Glycine soja; PHAS loci; PHAS-phasiRNA pathway; miRNA; phasiRNA; sliding window analysis
Mesh:
Substances:
Year: 2016 PMID: 27929436 PMCID: PMC5187843 DOI: 10.3390/ijms17122043
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Validation of differential expressions of sRNAs. The differential expressions of miRNAs and phasiRNAs identified by sRNA sequencing (right) were validated by qRT-PCR (left). Y-axis showed the normalized reads of sRNA in 14 samples (right) and relative expression levels (left). Error bar shows the standard deviation (SD) of the three biological replicates used in qRT-PCR.
Figure 2Pairwise correlation matrix of differentially-expressed miRNAs across tissue types, developmental stages, and wild and cultivated accessions. Pearson correlations between pairwise samples among all 14 experimental conditions were calculated by considering differentially-expressed miRNAs between each pairwise comparison as the distance between the two conditions. Blue boxes indicate positive correlation values (0 ≤ r ≤ 1; with 1 being complete positive correlation) and red boxes represent negative correlation values (−1 ≤ r ≤ 0, with −1 being complete anti-correlation) between samples. Correlation with p-values >0.1 are not shown in this matrix. The order of the rows was determined by the hierarchical clustering of the correlation matrix. Closely-related conditions, such as conditions with the same type of tissues, were therefore grouped together. “gca” and “gcr”: aerial part and roots, respectively, of germinated seedlings of C08; “yca” and “ycr”: aerial part and roots, respectively, of young seedlings of C08; “sct”: trifoliates of C08 seedlings; “scp” and “scr”: Primary leaves and roots, respectively, of C08; “gwa” and “gwr”: aerial part and roots, respectively, of germinated seedlings of W05; “ywa” and “ywr”: Aerial part and roots, respectively, of young seedlings of W05; “swt”: Trifoliates of W05 seedlings; “swp” and “swr”: Primary leaves and roots, respectively, of W05.
Figure 3Differential miRNA expressions between different samples. We studied miRNAs with >3000 counts in seven samples of C08 or W05. Differential expression analysis was performed between C08 samples and W05 samples (orange and red arrows), between leaf samples and root samples (blue arrows), and between developmental stages (green arrows). Details of these miRNAs are presented in Table S4.
Figure 4The pipeline for phasiRNA predictions: (A) The workflow for the comparisons between the phasiRNA profiles of C08 and W05. The numbers of common and unique phasiRNAs are shown in the Venn diagram; (B) The workflow for phasiRNA identification. Sequencing reads were mapped to the reference genome Gmax_275_Wm82.a2.v1 and only those reads that could be mapped to at most six positions on the reference genome with perfect matches were used. A sliding-window method was then applied to predict genome-wide PHAS regions using the pattern of mapped reads based on the ranking of p-values and phase scores. In each predicted PHAS region, loci with on-phase high-count reads (generating phasiRNAs >3000 total reads in seven sample of each variety) were selected and regarded as putative phasiRNA-generating loci. A characterization of each putative phasiRNA was performed to identify any possible miRNA triggers that initiated the biogenesis of phasiRNAs. The final product was a proposed pathway for each miRNA–phasiRNA pair.
PHAS regions and their annotations in soybean.
| Chr | PHAS Start | PHAS End | Accession | Gene Name | Homologous Gene | Annotation |
|---|---|---|---|---|---|---|
| Chr02 | 45,229,200 | 45,229,892 | C08 | NA | NA | NA |
| Chr03 | 35,270,999 | 35,271,544 | C08 | DTW domain-containing protein | ||
| Chr04 | 47,362,862 | 47,363,575 | C08 | NA | NA | NA |
| Chr04 | 49,035,971 | 49,037,012 | C08,W05 | Disease resistance protein (TIR-NB-LRR class) family | ||
| Chr05 | 656,827 | 657,414 | C08 | NB-ARC domain-containing disease resistance protein | ||
| Chr05 | 38,268,854 | 38,269,817 | C08,W05 | SGS3, XS zinc finger domain-containing protein | ||
| Chr06 | 11,932,996 | 11,934,011 | C08,W05 | Disease resistance protein (TIR-NB-LRR class) family | ||
| Chr06 | 19,392,730 | 19,393,674 | C08,W05 | Disease resistance protein (TIR-NB-LRR class), putative | ||
| Chr06 | 39,170,442 | 39,171,407 | W05 | Disease resistance protein (TIR-NB-LRR class), putative | ||
| Chr06 | 43,287,288 | 43,287,977 | C08,W05 | NB-ARC domain-containing disease resistance protein | ||
| Chr06 | 47,410,720 | 47,411,412 | C08,W05 | Disease resistance protein (TIR-NB-LRR class), putative | ||
| Chr07 | 4,028,350 | 4,029,084 | C08,W05 | NTL9 NAC transcription factor-like 9 | ||
| Chr08 | 41,923,481 | 41,923,921 | C08,W05 | Disease resistance protein (TIR-NB-LRR class) family | ||
| Chr08 | 41,923,963 | 41,924,634 | C08 | Disease resistance protein (TIR-NB-LRR class) family | ||
| Chr09 | 2,041,836 | 2,042,507 | C08,W05 | ATDCL2,DCL2 dicer-like 2 | ||
| Chr09 | 2,737,112 | 2,737,899 | C08,W05 | NA | NA | |
| Chr09 | 47,565,020 | 47,565,481 | W05 | Pentatricopeptide repeat (PPR) superfamily protein | ||
| Chr11 | 30,572,116 | 30,573,147 | C08,W05 | LRR and NB-ARC domains-containing disease resistance protein | ||
| Chr12 | 31,231,341 | 31,232,533 | C08,W05 | Disease resistance protein (TIR-NB-LRR class) family | ||
| Chr12 | 39,530,806 | 39,531,225 | C08 | NB-ARC domain-containing disease resistance protein | ||
| Chr13 | 19,268,532 | 19,269,329 | C08 | NA | NA | NA |
| Chr13 | 29,861,566 | 29,862,427 | C08 | LRR and NB-ARC domains-containing disease resistance protein | ||
| Chr13 | 29,875,305 | 29,876,627 | C08,W05 | NB-ARC domain-containing disease resistance protein | ||
| Chr13 | 30,174,985 | 30,175,782 | C08,W05 | NB-ARC domain-containing disease resistance protein | ||
| Chr13 | 30,207,736 | 30,208,554 | C08,W05 | NB-ARC domain-containing disease resistance protein | ||
| Chr13 | 30,389,026 | 30,390,362 | C08,W05 | NB-ARC domain-containing disease resistance protein | ||
| Chr13 | 30,664,791 | 30,665,882 | C08 | NB-ARC domain-containing disease resistance protein | ||
| Chr13 | 30,727,236 | 30,728,889 | C08,W05 | NB-ARC domain-containing disease resistance protein | ||
| Chr13 | 30,915,467 | 30,916,705 | C08,W05 | LRR and NB-ARC domains-containing disease resistance protein | ||
| Chr14 | 3,878,256 | 3,878,843 | C08 | NA | NA | NA |
| Chr15 | 43,699,964 | 43,700,551 | C08,W05 | Disease resistance protein (TIR-NB-LRR class) family | ||
| Chr15 | 43,746,080 | 43,746,499 | C08 | LRR and NB-ARC domains-containing disease resistance protein | ||
| Chr15 | 44,546,466 | 44,547,735 | C08,W05 | NA | NA | NA |
| Chr16 | 1,452,507 | 1,453,157 | C08,W05 | NTL9 NAC transcription factor-like 9 | ||
| Chr16 | 1,453,270 | 1,453,905 | C08 | NTL9 NAC transcription factor-like 9 | ||
| Chr16 | 1,461,742 | 1,462,416 | C08,W05 | NTL9 NAC transcription factor-like 9 | ||
| Chr16 | 1,462,506 | 1,463,177 | C08 | NTL9 NAC transcription factor-like 9 | ||
| Chr16 | 2,941,895 | 2,942,482 | C08,W05 | Nuclear transport factor 2 (NTF2) family protein | ||
| Chr16 | 4,855,988 | 4,856,743 | C08,W05 | AFB3 auxin signaling F-box 3 protein | ||
| Chr16 | 5,770,754 | 5,771,618 | C08,W05 | NA | NA | |
| Chr16 | 10,648,349 | 10,648,999 | C08,W05 | Disease resistance protein (TIR-NB-LRR class) family | ||
| Chr16 | 30,784,351 | 30,785,128 | C08,W05 | NA | NA | |
| Chr16 | 32,109,362 | 32,110,117 | C08,W05 | Pentatricopeptide repeat (PPR) superfamily protein | ||
| Chr16 | 32,167,989 | 32,168,613 | C08 | RPF2 RNA processing factor 2 | ||
| Chr16 | 32,182,422 | 32,182,883 | C08 | ATP binding;nucleic acid binding;helicases | ||
| Chr16 | 32,453,347 | 32,453,892 | W05 | Tetratricopeptide repeat (TPR)-like superfamily protein | ||
| Chr16 | 33,378,642 | 33,379,535 | W05 | NA | NA | |
| Chr16 | 35,681,818 | 35,682,321 | W05 | Tetratricopeptide repeat (TPR)-like superfamily protein | ||
| Chr16 | 35,687,005 | 35,687,634 | C08,W05 | Pentatricopeptide repeat (PPR) superfamily protein | ||
| Chr16 | 35,692,915 | 35,693,523 | C08,W05 | ATP binding;nucleic acid binding;helicases | ||
| Chr16 | 35,883,305 | 35,883,850 | W05 | Pentatricopeptide repeat (PPR) superfamily protein | ||
| Chr16 | 36,088,255 | 36,088,695 | C08,W05 | Tetratricopeptide repeat (TPR)-like superfamily protein | ||
| Chr16 | 36,970,009 | 36,970,575 | C08 | Disease resistance protein (TIR-NB-LRR class) family | ||
| Chr17 | 40,464,414 | 40,465,001 | C08,W05 | NA | NA | |
| Chr19 | 34,719,617 | 34,720,288 | C08,W05 | AFB3 auxin signaling F-box 3 protein | ||
| Chr19 | 40,040,875 | 40,041,548 | C08,W05 | NA | NA | NA |
| Chr20 | 31,854,969 | 31,855,514 | W05 | NA | NA | NA |
NA: Not found.
Changes in the abundances of phasiRNAs in W05 (wild) and C08 (cultivated) soybeans.
| Gene Name | Annotation | Number of phasiRNAs | Fold Change of Expression Level (W05/C08) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Ga | Gr | Ya | Yr | Sp | Sr | St | |||
| Disease resistance protein (TIR-NB-LRR class) | 4 | 1.1 | 0.6 | 1.1 | 0.7 | 1.2 | |||
| Disease resistance protein (TIR-NB-LRR class) | 4 | 1.4 | 0.9 | 1.1 | 0.6 | ||||
| Disease resistance protein (TIR-NB-LRR class) | 2 | 1.1 | 1.4 | 0.8 | 1.0 | 1.5 | |||
| Disease resistance protein (TIR-NB-LRR class) | 1 | 1.8 | 1.6 | 1.5 | 1.5 | 1.2 | 1.1 | ||
| Disease resistance protein (TIR-NB-LRR class) | 1 | 0.9 | 0.7 | 0.6 | 1.0 | ||||
| Disease resistance protein (TIR-NB-LRR class) | 2 | 0.6 | 0.9 | 1.1 | 1.3 | 1.1 | 0.6 | ||
| NB-ARC domain-containing disease resistance protein | 4 | 1.5 | |||||||
| LRR and NB-ARC domains-containing disease resistance protein | 1 | 0.6 | 0.6 | 1.0 | 0.8 | 1.5 | |||
| NTL9 NAC transcription factor-like 9 | 4 | 1.9 | 1.8 | 1.6 | 1.7 | ||||
| NTL9 NAC transcription factor-like 9 | 1 | 1.1 | 1.0 | 1.1 | |||||
| ATDCL2, DCL2 | 2 | 1.0 | 0.9 | 1.2 | 0.6 | 1.4 | 1.0 | ||
| AFB3 auxin signaling F-box 3 | 1 | 0.9 | 1.0 | 0.8 | 0.7 | 1.3 | |||
| Pentatricopeptide repeat (PPR) superfamily protein | 1 | 1.0 | 0.8 | 1.0 | 0.6 | 1.2 | 0.7 | ||
| NA | 3 | 1.0 | 0.9 | 1.0 | 0.6 | 1.1 | |||
| NA | 3 | 0.9 | 1.4 | 0.6 | 1.0 | 1.1 | 0.6 | ||
| NA | 4 | 0.6 | 0.6 | 0.8 | 0.9 | 0.6 | |||
| NA | 5 | 1.1 | 0.7 | 0.8 | 0.7 | 1.0 | |||
Ga: Germinated seedling aerial parts. Gr: Germinated seedling roots. Ya: Young seedling aerial parts. Yr: Young seedling roots. Sp: Seedling primary leaves. Sr: Seedling roots. St: Seedling trifoliates. Red: Fold change ≤0.5 (higher abundance in C08). Green: Fold change ≥2 (higher abundance in W05).
Differential amounts of phasiRNAs in the PHAS regions in leaves versus roots.
| Gene Name | Annotation | Number of phasiRNA | Leaf/Root (Germinated Seedlings) | Leaf/Root (Young Seedlings) | Leaf/Root (Seedlings) | Leaf/Root (Three Stages) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| C08 | W05 | C08 | W05 | C08 | W05 | C08 | W05 | |||
| Disease resistance protein (TIR-NB-LRR class) | 4 | 1.6 | ||||||||
| Disease resistance protein (TIR-NB-LRR class) | 4 | 0.8 | 1.8 | 1.2 | 1.0 | 1.2 | 1.4 | 1.3 | ||
| Disease resistance protein (TIR-NB-LRR class) | 2 | |||||||||
| Disease resistance protein (TIR-NB-LRR class) | 1 | |||||||||
| Disease resistance protein (TIR-NB-LRR class) | 1 | 0.6 | 1.5 | 1.1 | ||||||
| Disease resistance protein (TIR-NB-LRR class) | 2 | |||||||||
| NB-ARC domain-containing disease resistance protein | 4 | 1.1 | 1.4 | 1.4 | 1.6 | 1.9 | ||||
| LRR and NB-ARC domains-containing disease resistance protein | 1 | 1.2 | 1.3 | 0.7 | 1.7 | 1.0 | 1.2 | 0.8 | ||
| NTL9 NAC transcription factor-like 9 | 4 | 1.3 | 1.2 | 1.0 | 0.6 | 0.8 | 0.6 | |||
| NTL9 NAC transcription factor-like 9 | 1 | 1.0 | 1.2 | 0.6 | 0.7 | 1.5 | 1.2 | |||
| ATDCL2, DCL2 | 2 | 1.4 | 0.6 | 1.4 | 0.6 | 0.7 | 0.7 | |||
| AFB3 auxin signaling F-box 3 | 1 | 0.7 | 0.5 | |||||||
| Pentatricopeptide repeat (PPR) superfamily protein | 1 | |||||||||
| NA | 3 | 0.8 | 1.6 | 1.1 | 0.9 | 1.4 | 1.1 | 1.3 | ||
| NA | 3 | 0.9 | 1.0 | 0.5 | 1.6 | 0.8 | 0.8 | 0.7 | ||
| NA | 4 | 1.3 | ||||||||
| NA | 5 | 1.3 | ||||||||
Red: Fold change ≤0.5 (higher abundance in the roots); Green: Fold change ≥2 (high abundance in the leaves).